MEAGHAN SKROUPA: Open Payments
NPI 1245789783 · TROY, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$945 in 58 payments from 7 companies in 2025. Trend: 2023 $70 · 2024 $1,221 · 2025 $945
Food & beverage: $945
| Company | Payments | Amount |
|---|---|---|
| Edwards Lifesciences Corporation | 52 | $693 |
| Chiesi USA, Inc. | 1 | $130 |
| Biosense Webster, Inc. | 1 | $33 |
| Boston Scientific Corporation | 1 | $30 |
| Amgen Inc. | 1 | $24 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 1 | $21 |
| Alnylam Pharmaceuticals Inc. | 1 | $15 |
Products named: KENGREAL, CARTO 3, FARAPULSE, SAPIEN 3 Ultra RESILIA, TEZSPIRE, LifeVest, ONPATTRO.
Industry payments across NY — which companies pay providers there.
